Identi Healthcare Ltd (TLV:IDNT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 244.00
+7.90 (3.35%)
Aug 14, 2025, 5:24 PM IDT
Identi Healthcare Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 10.09 | 10.05 | 9.46 | 8.08 | 7.1 | Upgrade
|
| Revenue Growth (YoY) | 0.39% | 6.28% | 17.10% | 13.78% | 27.99% | Upgrade
|
| Cost of Revenue | 6.01 | 6.38 | 5.05 | 4.75 | 3.95 | Upgrade
|
| Gross Profit | 4.08 | 3.67 | 4.4 | 3.32 | 3.14 | Upgrade
|
| Selling, General & Admin | 6.94 | 7.25 | 7.45 | 3.14 | 1.25 | Upgrade
|
| Research & Development | 3.44 | 3.43 | 3.71 | 6.18 | 2.35 | Upgrade
|
| Operating Expenses | 10.39 | 10.68 | 11.15 | 9.31 | 3.6 | Upgrade
|
| Operating Income | -6.31 | -7.01 | -6.75 | -5.99 | -0.45 | Upgrade
|
| Interest Expense | -0.11 | -0.12 | -0.09 | -0.08 | -0.11 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.37 | 0.04 | - | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0 | 0.17 | -0.04 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.02 | 0.04 | 0.1 | -0.02 | Upgrade
|
| Pretax Income | -6.25 | -6.78 | -6.6 | -6.01 | -0.58 | Upgrade
|
| Income Tax Expense | 0.01 | - | 0.56 | -0.34 | 0.04 | Upgrade
|
| Net Income | -6.26 | -6.78 | -7.15 | -5.67 | -0.62 | Upgrade
|
| Net Income to Common | -6.26 | -6.78 | -7.15 | -5.67 | -0.62 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 13 | 11 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 11 | 9 | Upgrade
|
| Shares Change (YoY) | 0.06% | - | 15.17% | 21.59% | - | Upgrade
|
| EPS (Basic) | -0.50 | -0.54 | -0.57 | -0.52 | -0.07 | Upgrade
|
| EPS (Diluted) | -0.50 | -0.54 | -0.57 | -0.52 | -0.07 | Upgrade
|
| Free Cash Flow | -4.08 | -6.17 | -6.9 | -3.11 | -0.19 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.49 | -0.55 | -0.28 | -0.02 | Upgrade
|
| Gross Margin | 40.43% | 36.53% | 46.56% | 41.15% | 44.29% | Upgrade
|
| Operating Margin | -62.52% | -69.73% | -71.38% | -74.17% | -6.37% | Upgrade
|
| Profit Margin | -62.02% | -67.43% | -75.63% | -70.23% | -8.74% | Upgrade
|
| Free Cash Flow Margin | -40.44% | -61.38% | -72.98% | -38.56% | -2.73% | Upgrade
|
| EBITDA | -6.2 | -6.92 | -6.39 | -5.74 | -0.3 | Upgrade
|
| EBITDA Margin | -61.46% | -68.83% | -67.53% | -71.06% | -4.28% | Upgrade
|
| D&A For EBITDA | 0.11 | 0.09 | 0.36 | 0.25 | 0.15 | Upgrade
|
| EBIT | -6.31 | -7.01 | -6.75 | -5.99 | -0.45 | Upgrade
|
| EBIT Margin | -62.52% | -69.73% | -71.38% | -74.17% | -6.37% | Upgrade
|
| Advertising Expenses | 0.75 | 1.11 | 1.72 | 0.68 | 0.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.